Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Hepatic Fibrosis in a Long-term Murine Model of Sepsis.

Gonnert FA, Kunisch E, Gajda M, Lambeck S, Weber M, Claus RA, Bauer M, Kinne RW.

Shock. 2012 Apr;37(4):399-407. doi: 10.1097/SHK.0b013e31824a670b.

PMID:
22266973
2.
3.

Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation.

Carpino G, Morini S, Ginanni Corradini S, Franchitto A, Merli M, Siciliano M, Gentili F, Onetti Muda A, Berloco P, Rossi M, Attili AF, Gaudio E.

Dig Liver Dis. 2005 May;37(5):349-56.

PMID:
15843085
4.

MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis.

Ogawa T, Enomoto M, Fujii H, Sekiya Y, Yoshizato K, Ikeda K, Kawada N.

Gut. 2012 Nov;61(11):1600-9. Epub 2012 Jan 20.

PMID:
22267590
5.

Human amniotic epithelial cell transplantation induces markers of alternative macrophage activation and reduces established hepatic fibrosis.

Manuelpillai U, Lourensz D, Vaghjiani V, Tchongue J, Lacey D, Tee JY, Murthi P, Chan J, Hodge A, Sievert W.

PLoS One. 2012;7(6):e38631. doi: 10.1371/journal.pone.0038631. Epub 2012 Jun 14.

6.

Cooperation of liver cells in health and disease.

Kmieć Z.

Adv Anat Embryol Cell Biol. 2001;161:III-XIII, 1-151. Review.

PMID:
11729749
7.

Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts.

Trebicka J, Racz I, Siegmund SV, Cara E, Granzow M, Schierwagen R, Klein S, Wojtalla A, Hennenberg M, Huss S, Fischer HP, Heller J, Zimmer A, Sauerbruch T.

Liver Int. 2011 Jul;31(6):860-70. doi: 10.1111/j.1478-3231.2011.02496.x. Epub 2011 Mar 8.

PMID:
21645218
8.

Biliary intervention aggravates cholestatic liver injury, and induces hepatic inflammation, proliferation and fibrogenesis in BDL mice.

Wen YA, Liu D, Zhou QY, Huang SF, Luo P, Xiang Y, Sun S, Luo D, Dong YF, Zhang LP.

Exp Toxicol Pathol. 2011 Mar;63(3):277-84. doi: 10.1016/j.etp.2010.01.006. Epub 2010 Feb 10.

PMID:
20149605
9.

Kupffer cells are associated with apoptosis, inflammation and fibrotic effects in hepatic fibrosis in rats.

Liu C, Tao Q, Sun M, Wu JZ, Yang W, Jian P, Peng J, Hu Y, Liu C, Liu P.

Lab Invest. 2010 Dec;90(12):1805-16. doi: 10.1038/labinvest.2010.123. Epub 2010 Oct 4.

10.

Activated hepatic stellate cells in liver cirrhosis. A morphologic and morphometrical study.

Carpino G, Franchitto A, Morini S, Corradini SG, Merli M, Gaudio E.

Ital J Anat Embryol. 2004 Oct-Dec;109(4):225-38.

PMID:
15717457
11.

c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.

Giebeler A, Boekschoten MV, Klein C, Borowiak M, Birchmeier C, Gassler N, Wasmuth HE, Müller M, Trautwein C, Streetz KL.

Gastroenterology. 2009 Jul;137(1):297-308, 308.e1-4. doi: 10.1053/j.gastro.2009.01.068. Epub 2009 Feb 5.

PMID:
19208365
12.

GFAP expression in the liver as an early marker of stellate cells activation.

Morini S, Carotti S, Carpino G, Franchitto A, Corradini SG, Merli M, Gaudio E.

Ital J Anat Embryol. 2005 Oct-Dec;110(4):193-207.

PMID:
16536051
13.

Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats.

Abramovitch S, Dahan-Bachar L, Sharvit E, Weisman Y, Ben Tov A, Brazowski E, Reif S.

Gut. 2011 Dec;60(12):1728-37. doi: 10.1136/gut.2010.234666. Epub 2011 Aug 4.

PMID:
21816960
14.

The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse.

Canbay A, Feldstein A, Baskin-Bey E, Bronk SF, Gores GJ.

J Pharmacol Exp Ther. 2004 Mar;308(3):1191-6. Epub 2003 Nov 14.

15.

Involvement of STAT3-regulated hepatic soluble factors in attenuation of stellate cell activity and liver fibrogenesis in mice.

Shigekawa M, Takehara T, Kodama T, Hikita H, Shimizu S, Li W, Miyagi T, Hosui A, Tatsumi T, Ishida H, Kanto T, Hiramatsu N, Hayashi N.

Biochem Biophys Res Commun. 2011 Mar 25;406(4):614-20. doi: 10.1016/j.bbrc.2011.02.105. Epub 2011 Feb 26.

PMID:
21356197
16.

Endogenous alpha-calcitonin gene-related peptide mitigates liver fibrosis in chronic hepatitis induced by repeated administration of concanavalin A.

Kamiyoshi A, Sakurai T, Ichikawa-Shindo Y, Iinuma N, Kawate H, Yoshizawa T, Koyama T, Muto S, Shindo T.

Liver Int. 2009 May;29(5):642-9. doi: 10.1111/j.1478-3231.2008.01841.x. Epub 2008 Jul 30.

PMID:
18673438
17.

Hepatic stellate cell activation in genetic haemochromatosis. Lobular distribution, effect of increasing hepatic iron and response to phlebotomy.

Ramm GA, Crawford DH, Powell LW, Walker NI, Fletcher LM, Halliday JW.

J Hepatol. 1997 Mar;26(3):584-92.

PMID:
9075666
18.

A contributory role for activated hepatic stellate cells in the dynamics of Schistosoma japonicum egg-induced fibrosis.

Bartley PB, Ramm GA, Jones MK, Ruddell RG, Li Y, McManus DP.

Int J Parasitol. 2006 Aug;36(9):993-1001. Epub 2006 Jun 2.

PMID:
16806222
19.

Cocktail therapy with a combination of interferon, ribavirin and angiotensin-II type 1 receptor blocker attenuates murine liver fibrosis development.

Yoshiji H, Noguchi R, Ikenaka Y, Kaji K, Aihara Y, Shirai Y, Yoshii J, Yanase K, Fukui H.

Int J Mol Med. 2011 Jul;28(1):81-8. doi: 10.3892/ijmm.2011.658. Epub 2011 Mar 23.

PMID:
21455560
20.

Transplantation of human amnion epithelial cells reduces hepatic fibrosis in immunocompetent CCl₄-treated mice.

Manuelpillai U, Tchongue J, Lourensz D, Vaghjiani V, Samuel CS, Liu A, Williams ED, Sievert W.

Cell Transplant. 2010;19(9):1157-68. doi: 10.3727/096368910X504496. Epub 2010 May 4.

PMID:
20447339

Supplemental Content

Support Center